Tag: MMA embolisation
SwiftPAC opens door for standalone coiling in MMA embolisation procedures
NOTE: This video is ONLY available to watch in selected countries and geographies
With his interest in the endovascular treatment of chronic subdural haematoma...
SwiftPAC coil set to create new possibilities in MMA embolisation
This advertorial, intended only for audiences outside the USA, is sponsored by Penumbra.
Following its CE-mark approval and European commercial launch in September this year,...
Weighing up particles, EVOH-based liquid agents and glues in MMA embolisation
With the technique of middle meningeal artery embolisation (MMAe) presently coming of age in chronic subdural haematoma (cSDH) management, Franziska Dorn (Bonn, Germany) outlines...
Canadian RCT joins growing list of studies demonstrating benefits with MMA embolisation...
The findings of EMMA-CAN—the first randomised controlled trial (RCT) in Canada assessing embolisation of the middle meningeal artery (EMMA) as an adjunct to surgical...
Microparticle-based MMAe effect size “consistent with other trials” despite failure to...
Middle meningeal artery embolisation (MMAe) involving microparticles—as opposed to liquid embolic agents, glues or coils—did not lead to a statistically significant reduction in six-month...
Penumbra receives European CE mark for SwiftPAC neuroembolisation coils
Penumbra has secured CE-mark approval for its SwiftPAC neuroembolisation coil, which is part of the company’s Swift coil system. SwiftPAC coils are now commercially...
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Initial EMBODRAIN study results generate positivity around “tremendous revolution” in neurovascular...
Preliminary data on a transvascular platform for subdural haematoma (SDH) treatment—which involves performing middle meningeal artery (MMA) embolisation and haematoma drainage within a single...
Single-session MMA embolisation and surgical evacuation could enable more “resource-efficient” cSDH...
Performing a middle meningeal artery (MMA) embolisation procedure during the same anaesthesia session as a burr hole evacuation surgery represents a safe and potentially...
Arsenal Medical completes enrolment of initial EMBO-02 study cohort
Arsenal Medical has announced the complete enrolment of an initial cohort of 10 patients in the EMBO-02 clinical study evaluating NeoCast for the treatment...
Combined embolisation-drainage approach could be “transformational” next step in endovascular cSDH...
The past 18 months have seen a radical shift in clinical evidence supporting the role of middle meningeal artery embolisation (MMAe) within subdural haematoma...
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by...
Landmark MMA embolisation trials published in New England Journal of Medicine
Detailed results from three randomised controlled trials (RCTs) evaluating middle meningeal artery (MMA) embolisation in the treatment of chronic subdural haematoma (cSDH) have been...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
Recent breakthroughs in cSDH intervention may lead to “HERMES-style collaborative”
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural...
ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...
Phil White
Phil White’s career as a physician and researcher has seen him play a role in numerous major stroke trials, and serve as an educator...
